Molecular Pathogenesis of Myeloproliferative Disorders leaf node


URI

https://openalex.org/T11628

Label

Molecular Pathogenesis of Myeloproliferative Disorders

Description

This cluster of papers focuses on the molecular pathogenesis, diagnosis, treatment, and prognosis of myeloproliferative disorders such as polycythemia vera, essential thrombocythemia, and myelofibrosis. It covers topics such as JAK2 and CALR mutations, prognostic scoring systems, ruxolitinib therapy, hematologic response, leukemic transformation, and stem cell transplantation.

Implementation

@prefix oasubfields: <https://openalex.org/subfields/> .
@prefix openalex: <https://lambdamusic.github.io/openalex-hacks/ontology/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://openalex.org/T11628> a skos:Concept ;
    rdfs:label "Molecular Pathogenesis of Myeloproliferative Disorders"@en ;
    rdfs:isDefinedBy openalex: ;
    owl:sameAs <https://en.wikipedia.org/wiki/Myeloproliferative_neoplasm>,
        <https://openalex.org/T11628> ;
    skos:broader oasubfields:2716 ;
    skos:definition "This cluster of papers focuses on the molecular pathogenesis, diagnosis, treatment, and prognosis of myeloproliferative disorders such as polycythemia vera, essential thrombocythemia, and myelofibrosis. It covers topics such as JAK2 and CALR mutations, prognostic scoring systems, ruxolitinib therapy, hematologic response, leukemic transformation, and stem cell transplantation."@en ;
    skos:inScheme openalex: ;
    skos:prefLabel "Molecular Pathogenesis of Myeloproliferative Disorders"@en ;
    openalex:cited_by_count 474098 ;
    openalex:works_count 42065 .